Where Privia Health Gr Stands With Analysts

During the last three months, 9 analysts shared their evaluations of Privia Health Gr PRVA, revealing diverse outlooks from bullish to bearish.

The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $27.0, a high estimate of $37.00, and a low estimate of $21.00. A decline of 15.99% from the prior average price target is evident in the current average.

Interpreting Analyst Ratings: A Closer Look

In examining recent analyst actions, we gain insights into how financial experts perceive Privia Health Gr. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.

Key Insights:

• Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Privia Health Gr. This information offers a snapshot of how analysts perceive the current state of the company.
• Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Privia Health Gr compared to the broader market.
• Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Privia Health Gr's stock. This examination reveals shifts in analysts' expectations over time.

Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Privia Health Gr's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.

Stay up to date on Privia Health Gr analyst ratings.

Discovering Privia Health Gr: A Closer Look

Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings.

Privia Health Gr: A Financial Overview

Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.

Revenue Growth: Privia Health Gr's revenue growth over a period of 3 months has been noteworthy. As of 31 December, 2023, the company achieved a revenue growth rate of approximately 20.97%. This indicates a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Health Care sector.

Net Margin: Privia Health Gr's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 0.64% net margin, the company effectively manages costs and achieves strong profitability.

Return on Equity (ROE): Privia Health Gr's ROE excels beyond industry benchmarks, reaching 0.51%. This signifies robust financial management and efficient use of shareholder equity capital.

Return on Assets (ROA): Privia Health Gr's ROA excels beyond industry benchmarks, reaching 0.28%. This signifies efficient management of assets and strong financial health.

Debt Management: With a below-average debt-to-equity ratio of 0.01, Privia Health Gr adopts a prudent financial strategy, indicating a balanced approach to debt management.

Analyst Ratings: What Are They?

Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.

Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.

This article was generated by Benzinga's automated content engine and reviewed by an editor.